The dichotomy of TGF-β signaling playing a suppressive role in premalignant cells and a stimulatory role in cancer cells has been attributed to contextual determinants that promote TGF-β mediated epithelial mesenchymal transition (EMT) while simultaneously restricting the cytostatic effects of TGF-β [14, 15]. The gene discussed is TGFB1; the disease is cancer.